Plus Therapeutics, Inc. (PSTV)

Plus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.29	0.08	8.55	18.12	18.4	8.35
Short-Term Investments	3.31	3.53	-	-	-	-
Cash & Short-Term Investments	16.6	3.61	8.55	18.12	18.4	8.35
Cash Growth	246.72%	-57.84%	-52.79%	-1.52%	120.47%	-52.45%
Accounts Receivable	-	0.57	-	-	-	-
Receivables	-	0.57	-	-	-	-
Prepaid Expenses	-	0.65	1.05	3.7	1.32	0.77
Other Current Assets	0.99	0.44	0.23	-	0.01	0.06
Total Current Assets	17.59	5.26	9.83	21.82	19.72	9.18
Property, Plant & Equipment	0.29	0.52	1.11	1.57	1.82	2.46
Goodwill	0.37	0.37	0.37	0.37	0.37	0.37
Other Intangible Assets	0.37	0.47	0.04	0.09	0.05	0.09
Other Long-Term Assets	0.05	0.01	0.03	0.01	0.02	0.02
Total Assets	18.67	6.63	11.39	23.87	21.98	12.11
Accounts Payable	11.62	9.47	4.76	8.36	2.61	0.79
Accrued Expenses	-	1.81	1.87	1.77	1.42	1.26
Short-Term Debt	-	3.29	-	-	-	-
Current Portion of Long-Term Debt	-	-	3.98	1.61	1.61	6.34
Current Portion of Leases	0.02	0.04	0.12	0.11	0.11	0.13
Current Unearned Revenue	1.97	0.93	-	-	-	-
Other Current Liabilities	-	-	-	-	0.12	0.02
Total Current Liabilities	13.62	15.55	10.73	11.85	5.87	8.54
Long-Term Debt	-	-	-	3.79	5.01	-
Long-Term Leases	-	0.03	0.09	0.14	0.27	0.53
Long-Term Unearned Revenue	-	-	1.92	1.64	-	-
Other Long-Term Liabilities	-	-	-	-	0	0.01
Total Liabilities	13.62	15.58	12.74	17.42	11.15	9.07
Common Stock	0.13	0.01	0.01	0	0.02	0.01
Additional Paid-In Capital	515.57	485.02	479.27	473.63	457.73	436.54
Retained Earnings	-510.15	-493.48	-480.5	-467.19	-446.91	-433.51
Treasury Stock	-0.5	-0.5	-0.13	-	-	-
Shareholders' Equity	5.05	-8.95	-1.35	6.45	10.84	3.03
Total Liabilities & Equity	18.67	6.63	11.39	23.87	21.98	12.11
Total Debt	0.02	3.37	4.18	5.65	6.99	7
Net Cash (Debt)	16.58	0.24	4.37	12.48	11.41	1.35
Net Cash Growth	1094.52%	-94.53%	-64.95%	9.36%	744.96%	-75.77%
Net Cash Per Share	0.37	0.03	1.39	7.13	14.15	4.57
Filing Date Shares Outstanding	137.43	17	4.28	2.34	1.48	0.45
Total Common Shares Outstanding	131.61	5.9	4.44	2.24	1.03	0.45
Working Capital	3.97	-10.29	-0.89	9.97	13.85	0.64
Book Value Per Share	0.04	-1.52	-0.30	2.88	10.48	6.74
Tangible Book Value	4.31	-9.79	-1.76	5.98	10.41	2.57
Tangible Book Value Per Share	0.03	-1.66	-0.40	2.67	10.07	5.72
Machinery	-	1.78	1.63	1.47	1.23	1.53
Leasehold Improvements	-	1.81	1.81	1.81	1.66	1.68

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q